Semax 60mg — Vial Spec, Reconstitution Math & COA

Direct Answer: What Is a Semax 60mg Research Vial Specification?

A 60mg Semax vial is a high-yield, lyophilized research unit containing 60 milligrams of the synthetic heptapeptide sequence Met-Glu-His-Phe-Pro-Gly-Pro. This specific mass format is intended primarily for institutional laboratories, high-throughput in vitro screening, and multi-subject preclinical rodent trials where large volumetric batches are required to minimize intra-assay variance.

It is important to note that while custom high-yield formats like 60mg exist for bulk processing, PX1 Research currently stocks standard inventory in optimized sizes such as the Semax 30mg format. Researchers seeking diverse inventory formats can view our complete catalog via all peptides. Regardless of total mass per vial, all Semax prepared by PX1 Research undergoes rigorous HPLC/MS testing to verify sequence identity and purity prior to distribution.

High-Yield Format Utility: Who Orders the 60mg Mass Specification?

The 60mg vial configuration is selected by research teams executing large-scale experimental designs where standard 5mg or 10mg vials would necessitate frequent reconstitution events. Reconstituting multiple small vials introduces minor volumetric handling errors and batch-to-batch dilution inconsistencies that can confound statistical power in controlled studies.

Primary facilities ordering 60mg specifications include university neuroscience laboratories conducting automated cell culture assays, contract research organizations (CROs) evaluating neurotrophic signaling pathways, and institutional groups performing comparative peptidomimetic research. Ordering high-yield units also reduces packaging waste and streamlines storage management within -20°C and -80°C laboratory freezer inventories.

Reconstitution Mathematics for 60mg Semax Vials

Accurate volumetric concentration calculations are critical when preparing a 60mg lyophilized cake for downstream pipetting. Because 60mg represents a substantial mass of active peptide, selecting the appropriate volume of sterile diluent—such as Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS)—directly determines working solution viscosity and aliquot volume precision.

Below are the primary concentration ratios achieved when adding 1 mL, 2 mL, or 3 mL of solvent to a 60mg Semax vial. For precise micro-liter volumetric mapping across custom diluent volumes, researchers should utilize our interactive reconstitution calculator:

Detailed Volumetric Calculations (1 mL, 2 mL, and 3 mL Diluent)

1. **Reconstitution with 1.0 mL Diluent:** Adding 1.0 mL of liquid yield results in a final concentration of 60.0 mg/mL (equivalent to 60.0 µg per microliter [µL]). This highly concentrated stock solution is ideal for automated microplate dispensers where sub-microliter addition is required to prevent buffer dilution in biological assays.

2. **Reconstitution with 2.0 mL Diluent:** Adding 2.0 mL of solvent yields a working stock concentration of 30.0 mg/mL (30.0 µg/µL). This medium-density concentration provides an ideal balance between fluid dynamics and pipetting accuracy for standard low-binding micropipette tips.

3. **Reconstitution with 3.0 mL Diluent:** Adding 3.0 mL of solvent results in a concentration of 20.0 mg/mL (20.0 µg/µL). This diluted concentration is preferred when manual micropipetting requires larger, highly repeatable injection or dispensation volumes (e.g., 5 µL to 10 µL aliquots representing 100 µg to 200 µg of compound).

Aliquot Planning and Preventing Freeze-Thaw Degradation

High-mass peptide reconstitutions must be managed carefully to avoid repeated freeze-thaw cycles, which induce mechanical shear stress and thermal degradation of the peptide backbone. Once a 60mg Semax vial is fully dissolved, the master solution should immediately be divided into single-use polypropylene micro-centrifuge tubes.

For example, a 60mg cake reconstituted in 3.0 mL of bacteriostatic water (20 mg/mL) can be partitioned into thirty 100 µL aliquots, each containing exactly 2.0 mg of Semax. These secondary working tubes can be frozen at -20°C or -80°C and thawed individually as needed for daily in vitro protocols, guaranteeing that the bulk inventory remains stable over extended experimental timelines.

Molecular Structure, Synthetic Chemistry, and In Vitro Mechanisms

Semax is a synthetic analog of the adrenocorticotropic hormone fragment ACTH (4-10), modified with a C-terminal Pro-Gly-Pro tripeptide sequence to significantly enhance metabolic stability against circulating peptidases. In preclinical literature, Semax has been investigated for its influence on neurotrophin expression, specifically brain-derived neurotrophic factor (BDNF) and tropomyosin receptor kinase B (TrkB) signaling cascades in neuronal cell cultures.

In vitro data indicate that Semax alters gene expression patterns associated with neuroplasticity and inflammatory pathways without binding directly to classical ACTH steroidogenic receptors. Preclinical rodent models further demonstrate that the peptide modulates central neurotransmitter systems, including dopaminergic and serotonergic turnover, providing a rich framework for ongoing neurobiological investigation.

Storage and Handling Protocols for Lyophilized and Solubilized Semax

Lyophilized Semax powder exhibits robust physical stability when stored in desiccated conditions away from direct light. Long-term storage of intact 60mg vials should be maintained at -20°C or -80°C. Under these ultra-low temperature conditions, the un-reconstituted peptide cake maintains structural integrity for up to 24 months.

Following reconstitution, liquid solutions should be stored under refrigeration at 2°C to 8°C if they are to be consumed within 14 to 21 days (when dissolved in bacteriostatic water). If reconstituted in sterile unpreserved saline or PBS, the solution must be used immediately or sub-aliquoted and stored at -20°C. Exposure to ambient temperatures above 25°C for extended periods accelerates hydrolytic cleavage and should be strictly avoided.

Comparative Analysis: Semax, Selank, and Related Neuropeptides

When designing neuropeptide screening protocols, principal investigators frequently compare Semax to other regulatory peptides in the same structural or functional class. For example, while Semax derives from ACTH (4-10), Selank is a synthetic hexapeptide derived from the immunomodulatory peptide tuftsin. Preclinical studies suggest that while Semax primarily impacts BDNF pathways and executive neurocircuitry in rodent models, Selank exhibits pronounced effects on GABAergic neurotransmission and interleukin-6 expression.

Additionally, modified analogs such as N-Acetyl Semax Amidate feature N-terminal acetylation and C-terminal amidation designed to resist enzymatic degradation even further than native Semax. Researchers evaluating systemic tissue repair pathways alongside central nervous system targets may also incorporate non-neural peptides like BPC-157 into multi-compound preclinical assays. Selecting the correct compound and vial size depends entirely on the specific receptor pathways under observation.

Analytical Verification: Reading a Lot-Matched COA

Every research compound distributed by PX1 Research undergoes rigorous third-party testing in an ISO 17025 accredited analytical facility. To verify purity and sequence identity, researchers can review our public COA library. A lot-matched Certificate of Analysis provides two primary analytical benchmarks:

First, High-Performance Liquid Chromatography (HPLC) confirms chemical purity, verifying that the main peptide peak constitutes ≥98.0% of the total integrated area. Second, Mass Spectrometry (MS) confirms molecular weight, demonstrating that the observed mass-to-charge ratio matches the theoretical molecular mass of Semax (810.9 g/mol). These assays ensure that experimental data are free from artifacts caused by synthesis side-products or residual trifluoroacetate (TFA) salts.

Quality Control, Endotoxin Limits, and GMP Compliance

In addition to identity and purity testing, high-concentration peptide preparations must adhere to strict biological contamination standards. PX1 Research subjects every batch to Chromogenic Reagent Limulus Amebocyte Lysate (LAL) testing to quantify bacterial endotoxin levels. Endotoxin levels are verified to remain below stringent threshold limits (<0.05 EU/mg), preventing non-specific inflammatory responses in delicate cell culture models.

All PX1 peptides are manufactured in USA-based, GMP-compliant facilities utilizing solid-phase peptide synthesis (SPPS) technology. Vials are stoppered and crimped under filtered laminar flow hoods to guarantee sterility upon receipt. Qualified laboratories interested in bulk procurement or customized batch fills can establish institutional accounts via our wholesale portal.